Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 47

1.

Intrapericardial delivery of amiodarone rapidly achieves therapeutic levels in the atrium.

Marcano J, Campos K, Rodriguez V, Handy K, Brewer MA, Cohn WE.

Heart Surg Forum. 2013 Oct;16(5):E279-86.

PMID:
24364084
2.

Inhibition of DNA methyltransferases, histone deacetylases and lysine-specific demethylase-1 suppresses the tumorigenicity of the ovarian cancer ascites cell line SKOV3.

Meng F, Sun G, Zhong M, Yu Y, Brewer MA.

Int J Oncol. 2013 Aug;43(2):495-502. doi: 10.3892/ijo.2013.1960. Epub 2013 May 24.

PMID:
23709006
3.

7,12-dimethylbenz[a]anthracene-induced malignancies in a mouse model of menopause.

Marion SL, Watson J, Sen N, Brewer MA, Barton JK, Hoyer PB.

Comp Med. 2013 Feb;63(1):6-12.

4.

Anticancer efficacy of cisplatin and trichostatin A or 5-aza-2'-deoxycytidine on ovarian cancer.

Meng F, Sun G, Zhong M, Yu Y, Brewer MA.

Br J Cancer. 2013 Feb 19;108(3):579-86. doi: 10.1038/bjc.2013.10. Epub 2013 Jan 31.

5.

Two-photon excited fluorescence imaging of endogenous contrast in a mouse model of ovarian cancer.

Watson JM, Marion SL, Rice PF, Utzinger U, Brewer MA, Hoyer PB, Barton JK.

Lasers Surg Med. 2013 Mar;45(3):155-66. doi: 10.1002/lsm.22115. Epub 2013 Jan 29.

PMID:
23362124
6.

Analysis of second-harmonic-generation microscopy in a mouse model of ovarian carcinoma.

Watson JM, Rice PF, Marion SL, Brewer MA, Davis JR, Rodriguez JJ, Utzinger U, Hoyer PB, Barton JK.

J Biomed Opt. 2012 Jul;17(7):076002. doi: 10.1117/1.JBO.17.7.076002.

7.

Parallel factor analysis of ovarian autofluorescence as a cancer diagnostic.

George R, Michaelides M, Brewer MA, Utzinger U.

Lasers Surg Med. 2012 Apr;44(4):282-95. doi: 10.1002/lsm.22014. Epub 2012 Mar 7.

PMID:
22407572
8.

Exemestane for breast-cancer prevention in postmenopausal women.

Goss PE, Ingle JN, Alés-Martínez JE, Cheung AM, Chlebowski RT, Wactawski-Wende J, McTiernan A, Robbins J, Johnson KC, Martin LW, Winquist E, Sarto GE, Garber JE, Fabian CJ, Pujol P, Maunsell E, Farmer P, Gelmon KA, Tu D, Richardson H; NCIC CTG MAP.3 Study Investigators.

N Engl J Med. 2011 Jun 23;364(25):2381-91. doi: 10.1056/NEJMoa1103507. Epub 2011 Jun 4. Erratum in: N Engl J Med. 2011 Oct 6;365(14):1361.

9.

Simultaneous optical coherence tomography and laser induced fluorescence imaging in rat model of ovarian carcinogenesis.

Hariri LP, Liebmann ER, Marion SL, Hoyer PB, Davis JR, Brewer MA, Barton JK.

Cancer Biol Ther. 2010 Sep 1;10(5):438-47.

10.

Clinical research device for ovarian cancer detection by optical spectroscopy in the ultraviolet C-visible.

George R, Chandrasekaran A, Brewer MA, Hatch KD, Utzinger U.

J Biomed Opt. 2010 Sep-Oct;15(5):057009. doi: 10.1117/1.3503468.

11.

Overexpression of tumor vascular endothelial growth factor A may portend an increased likelihood of progression in a phase II trial of bevacizumab and erlotinib in resistant ovarian cancer.

Chambers SK, Clouser MC, Baker AF, Roe DJ, Cui H, Brewer MA, Hatch KD, Gordon MS, Janicek MF, Isaacs JD, Gordon AN, Nagle RB, Wright HM, Cohen JL, Alberts DS.

Clin Cancer Res. 2010 Nov 1;16(21):5320-8. doi: 10.1158/1078-0432.CCR-10-0974.

12.

Alterations of the extracellular matrix in ovarian cancer studied by Second Harmonic Generation imaging microscopy.

Nadiarnykh O, LaComb RB, Brewer MA, Campagnola PJ.

BMC Cancer. 2010 Mar 11;10:94. doi: 10.1186/1471-2407-10-94.

13.

Adhesion and migration of ovarian cancer cells on crosslinked laminin fibers nanofabricated by multiphoton excited photochemistry.

Chen X, Brewer MA, Zou C, Campagnola PJ.

Integr Biol (Camb). 2009 Jul;1(7):469-76. doi: 10.1039/b906310b. Epub 2009 Jun 11.

14.

The potential of biologic network models in understanding the etiopathogenesis of ovarian cancer.

Khalil I, Brewer MA, Neyarapally T, Runowicz CD.

Gynecol Oncol. 2010 Feb;116(2):282-5. doi: 10.1016/j.ygyno.2009.10.085. Review.

PMID:
19931138
15.

Pediatric falls: state of the science.

Child Health Corporation of America Nursing Falls Study Task Force.

Pediatr Nurs. 2009 Jul-Aug;35(4):227-31.

PMID:
19785302
16.

Laparoscopic optical coherence tomography imaging of human ovarian cancer.

Hariri LP, Bonnema GT, Schmidt K, Winkler AM, Korde V, Hatch KD, Davis JR, Brewer MA, Barton JK.

Gynecol Oncol. 2009 Aug;114(2):188-94. doi: 10.1016/j.ygyno.2009.05.014. Epub 2009 May 29.

17.

A collaborative approach to building the capacity for research and evidence-based practice in community hospitals.

Brewer BB, Brewer MA, Schultz AA.

Nurs Clin North Am. 2009 Mar;44(1):11-25, ix. doi: 10.1016/j.cnur.2008.10.003. Review.

PMID:
19167545
18.

Ovarian neoplasm development by 7,12-dimethylbenz[a]anthracene (DMBA) in a chemically-induced rat model of ovarian failure.

Hoyer PB, Davis JR, Bedrnicek JB, Marion SL, Christian PJ, Barton JK, Brewer MA.

Gynecol Oncol. 2009 Mar;112(3):610-5. doi: 10.1016/j.ygyno.2008.12.013. Epub 2009 Jan 16.

19.

Devices in heart failure: potential methods for device-based monitoring of congestive heart failure.

Munir SM, Bogaev RC, Sobash E, Shankar KJ, Gondi S, Stupin IV, Robertson J, Brewer MA, Casscells SW, Delgado RM, Ahmed A.

Tex Heart Inst J. 2008;35(2):166-73. Review.

20.

Computer-aided identification of ovarian cancer in confocal microendoscope images.

Srivastava S, Rodríguez JJ, Rouse AR, Brewer MA, Gmitro AF.

J Biomed Opt. 2008 Mar-Apr;13(2):024021. doi: 10.1117/1.2907167.

PMID:
18465984
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk